Rabbit Recombinant Monoclonal HIAT1 antibody. Suitable for WB and reacts with Human samples.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | |
---|---|
Human | Tested |
Mouse | Predicted |
Rat | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
HIAT1, MFSD14A, Hippocampus abundant transcript 1 protein, Major facilitator superfamily domain-containing 14A, Putative tetracycline transporter-like protein
Rabbit Recombinant Monoclonal HIAT1 antibody. Suitable for WB and reacts with Human samples.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
HIAT1 also known as hippocampus abundant transcript 1 protein is a transmembrane protein with a mass of approximately 28 kDa. This protein is located in the cell membrane and shows expression in various tissues but it is more abundant in the brain especially within the hippocampus. Research shows that HIAT1 participates in regulating ion transport across the cell membrane which is important for maintaining cellular homeostasis.
This protein plays a role in neuronal function and development. It is part of a larger molecular complex that influences synaptic transmission and plasticity. HIAT1 has a significant impact on neuronal signaling by interacting with specific receptors and ion channels. This involvement suggests that the protein has a potential influence on learning and memory processes reflecting its expression pattern in the brain.
HIAT1 significantly engages in neural communication pathways that are critical for brain function. It interacts with the glutamatergic signaling pathway which is essential for excitatory synaptic transmission. Connections exist between HIAT1 and other proteins like NMDA receptors contributing to synapse modulation and neuronal excitability. Additionally HIAT1 may influence the calcium signaling pathway to affect cellular responses to stimuli.
Disruptions or alterations in HIAT1 expression have been linked to neurological conditions such as epilepsy and Alzheimer's disease. Abnormal HIAT1 function may affect proteins like amyloid precursor protein (APP) highlighting its potential role in the pathogenesis of Alzheimer's. In epilepsy changes in HIAT1 might contribute to altered neuronal excitability suggesting its involvement in the disease's development and progression.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-HIAT1 antibody [EPR9642] (ab181050) at 1/10000 dilution
All lanes: Human fetal brain lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab136636) at 1/1000 dilution
Predicted band size: 53 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com